Feldan Therapeutics is developing leading-edge treatments based on a unique intracellular delivery technology; the Feldan Shuttle.
Location: Canada, Ontario, Toronto
Employees: 11-50
Total raised: $16.5M
Founded date: 2007
Investors 3
| Date | Name | Website |
| 01.11.2024 | Genesys Ca... | genesyscap... |
| - | Groupe Ros... | grouperosk... |
| - | Anges Québ... | angesquebe... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.06.2023 | Series B | $16.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 18.04.2025 | Feldan Therapeutics: Investment Raised From Zynext Ventures | Zynext Ventures, the VC arm of Zydus Lifesciences, announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage pharmaceutical company pioneering the development of treatments based on intracellular delivery... |
| 17.04.2025 | Feldan Therapeutics Receives Investment from Zynext Ventures | Feldan Therapeutics, a Québec City, Québec, Canada-based early clinical-stage pharmaceutical company, received an investment from Zynext Ventures. The amount of the deal was not disclosed. The company intends to use the funds to expand oper... |
| 13.06.2023 | Feldan Therapeutics Holds Initial Closing of $16.5M Series B Funding | Feldan Therapeutics, a Quebec City, Canada-based biopharmaceutical company that specializes in the development of treatments based on intracellular delivery of therapeutics, raised $16.5M in Series B funding. Backers included Investissement... |
| - | Feldan Therapeutics | “Feldan Therapeutics - Home” |